AR127170A1 - Antagonistas del receptor de la hormona paratiroidea (pth) y sus usos - Google Patents
Antagonistas del receptor de la hormona paratiroidea (pth) y sus usosInfo
- Publication number
- AR127170A1 AR127170A1 ARP220102606A ARP220102606A AR127170A1 AR 127170 A1 AR127170 A1 AR 127170A1 AR P220102606 A ARP220102606 A AR P220102606A AR P220102606 A ARP220102606 A AR P220102606A AR 127170 A1 AR127170 A1 AR 127170A1
- Authority
- AR
- Argentina
- Prior art keywords
- pth
- parathyroid hormone
- pharmaceutically acceptable
- receptor antagonists
- solvate
- Prior art date
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title abstract 5
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 5
- 239000000199 parathyroid hormone Substances 0.000 title abstract 5
- 229960001319 parathyroid hormone Drugs 0.000 title abstract 5
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En el presente documento, se describen compuestos que son moduladores del receptor de la hormona paratiroidea (PTH), métodos para hacerlos, composiciones farmacéuticas y medicamentos que los comprenden y métodos para utilizar tales compuestos en el tratamiento de afecciones, enfermedades o trastornos que se beneficiarían a partir de la modulación de la actividad del receptor de PTH. Un compuesto de la fórmula (1) o una sal o solvato farmacéuticamente aceptable de este. Una composición farmacéutica caracterizada porque comprende un compuesto de una cualquiera de las reivindicaciones 1 a 52 o una sal o un solvato farmacéuticamente aceptables de este y al menos un excipiente farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163250827P | 2021-09-30 | 2021-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR127170A1 true AR127170A1 (es) | 2023-12-27 |
Family
ID=85783491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220102606A AR127170A1 (es) | 2021-09-30 | 2022-09-28 | Antagonistas del receptor de la hormona paratiroidea (pth) y sus usos |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230159532A1 (es) |
| AR (1) | AR127170A1 (es) |
| TW (1) | TW202330520A (es) |
| WO (1) | WO2023055827A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025117439A1 (en) * | 2023-11-30 | 2025-06-05 | Viva Star Biosciences (Us) Inc. | Macrocycle compounds as inhibitors of nlrp3 activity and therapeutic uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19963868A1 (de) * | 1999-12-30 | 2001-07-12 | Boehringer Ingelheim Pharma | Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| GB0511410D0 (en) * | 2005-06-03 | 2005-07-13 | James Black Foundation | Benzotrizepinone derivatives |
| WO2014145909A2 (en) * | 2013-03-15 | 2014-09-18 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone compounds and methods of treating disorders |
-
2022
- 2022-09-28 AR ARP220102606A patent/AR127170A1/es unknown
- 2022-09-28 WO PCT/US2022/045078 patent/WO2023055827A1/en not_active Ceased
- 2022-09-29 US US17/936,508 patent/US20230159532A1/en not_active Abandoned
- 2022-09-30 TW TW111137152A patent/TW202330520A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023055827A1 (en) | 2023-04-06 |
| TW202330520A (zh) | 2023-08-01 |
| US20230159532A1 (en) | 2023-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP24014832A (es) | Inhibidores de nlrp3 | |
| PE20191615A1 (es) | Compuestos quimicos como inhibidores de la actividad de la interleuquina-1 | |
| CR20210552A (es) | Inhibidores del inflamasoma nlrp3 | |
| CO2019010078A2 (es) | Compuestos de pirimidinil-pyridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1 | |
| AR128931A1 (es) | Inhibidores del factor b del complemento y usos de los mismos | |
| UY34974A (es) | Piridazina 1,4 disustituida, análogos de la misma y métodos para tratar las enfermedades relacionadas con deficiencia del smn | |
| MX2021009561A (es) | Compuestos de tetrahidroquinolinona sustituidos como moduladores de ror gamma. | |
| EA202090573A1 (ru) | Составы нирапариба | |
| ECSP19078393A (es) | Compuestos inhibidores de ask1 y usos de los mismos | |
| HN2011001358A (es) | Moduladores de aril metil benzoquinazolina alostericos positivos del receptor m1 | |
| MX2022004451A (es) | Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1. | |
| CO2017012545A2 (es) | Sulfonas tricíclicas como moduladores del receptor huérfano relacionado con retinoide gamma (rorγ) | |
| AR123685A1 (es) | Antagonistas del mrgx2 | |
| ECSP19072975A (es) | Derivados pirazol[1,5-a]pirimidina sustituidos con alicíclicos farmacológicamente activos | |
| AR054786A1 (es) | (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1 | |
| AR127470A1 (es) | Inhibidores de lrrk2 | |
| MX2020004667A (es) | Compuestos, composiciones y metodos para el tratamiento de trastornos oculares y enfermedades cutaneas. | |
| AR128109A1 (es) | Spiros y análogos relacionados para inhibir yap / taz-tead | |
| CO2024017138A2 (es) | Compuestos amido heteroaromáticos útiles en el tratamiento de enfermedades hepáticas | |
| PE20181328A1 (es) | Compuestos de dihidroquinolinsulfonamida de alquilo | |
| CO2023002940A2 (es) | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmacéuticos de los mismos | |
| CL2023000086A1 (es) | Análogos de insulina novedosos y usos de estos(div 202201400) | |
| AR127170A1 (es) | Antagonistas del receptor de la hormona paratiroidea (pth) y sus usos | |
| AR050914A1 (es) | Agonista receptor de vasopresina peptidico | |
| CL2021000627A1 (es) | Composiciones farmacéuticas adecuadas para liberación articular y su uso en el tratamiento del dolor articular |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |